Clinical Trial Update: Cresemba® in Treating Chinese Patients With IFD Caused by Aspergillus Species or Other Filamentous Fungi [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating completion of the study of Pfizer's Cresemba (posaconazole) for invasive fungal disease due to Aspergillus species or other fila…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis
• Invasive Fungal Infection

Drugs mentioned

• Cresemba (isavuconazole)

Snippet

Sponsor: Pfizer | Conditions: Invasive Fungal Disease | Phase 4 | Status: COMPLETED